GlaxoSmithKline Pharmaceuticals informs about issuance of duplicate share certificate

27 Oct 2022 Evaluate

Pursuant to Regulation 39 and other application regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the ‘Regulations’), GlaxoSmithKline Pharmaceuticals has informed that Registrar and Transfer Agent of Company - KFin Technologies has received request for issue of duplicate Share Certificates from Shareholder, as per the details attached. The company will issue the duplicate Share Certificate(s) only after the necessary formalities are carried out by the shareholder(s).

The above information is a part of company’s filings submitted to BSE.

Glaxosmithkline Phar Share Price

2338.15 -10.55 (-0.45%)
19-Jan-2026 11:53 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1682.40
Dr. Reddys Lab 1173.10
Cipla 1386.90
Zydus Lifesciences 867.25
Lupin 2185.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×